• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Generic Biologics Face Uphill Battle

    Morningstar generic-pharmaceuticals analyst Brian Laegeler discusses the outlook for generic biologics in the U.S. given a strong branded-drug lobby and complex manufacturing processes.

  2. Going Global to Ease Drug Trial Process

    Contract research organization Parexel is exploiting its global footprint to rapidly enroll patients in drug studies.

  3. After Reform, Opportunity

    Associate director for health-care analysis Alex Morozov on the uncertainty-overhang relief, biggest winners, and best values in post-reform health care.

  4. Will a Medco/Express Scripts Merger Pass Regulatory Muster?

    Shareholders would be well-served by the pharmacy benefit managers' merger, but regulators are unlikely to sign off on it, says Morningstar's Matt Coffina.

  1. Cubist Pharmaceuticals, Inc. CBST Q2 2010 Earnings Call Transcript

    Greetings and welcome to the Cubist Pharmaceuticals' Second Quarter 2010 Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Eileen McIntyre, for Cubist Pharmaceuticals. Thank you, you may begin.

  2. A Midyear Checkup on the Health-Care Sector

     

  3. Gilead Sciences, Inc. GILD Q1 2010 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by. We would like to welcome you to the Gilead Sciences First Quarter 2010 Earnings Conference Call. My name is Stacy and I will be your conference operator for today.

  4. Emerging Nations: A Blossoming Field For Drug and Medical-Device Firms

     

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.